[1] |
LI Junjie.
Progress and future prospects in local and systemic treatment of early breast cancer
[J]. China Oncology, 2025, 35(2): 205-212.
|
[2] |
LU Yongjin, SHI Zhiqiang, LI Tong, WANG Yongsheng, QIU Pengfei.
Retrospective study on regional lymph node radiotherapy after axillary dissection exemption in breast cancer patients with sentinel lymph node positive status
[J]. China Oncology, 2025, 35(2): 228-236.
|
[3] |
WU Wen, ZHANG Ruoxin, WENG Junyong, MA Yanlei, CAI Guoxiang, LI Xinxiang, YANG Yongzhi.
Exploring the prognostic value of positive lymph node ratio in stage Ⅲ colorectal cancer patients and establishing a predictive model
[J]. China Oncology, 2024, 34(9): 873-880.
|
[4] |
MA Fenghua, JIANG Anqi, CHEN Yiqing, XU Congjian, KANG Yu.
Magnetic resonance imaging for distinguishing gastric-type endocervical adenocarcinoma from lobular endocervical glandular hyperplasia
[J]. China Oncology, 2024, 34(4): 380-388.
|
[5] |
GUO Ye, ZHANG Chenping.
Expert consensus on immune checkpoint inhibitors treatment for recurrent/metastatic head and neck squamous cell carcinoma (2024 edition)
[J]. China Oncology, 2024, 34(4): 425-438.
|
[6] |
WU Siyu, LI Junjie, SHAO Zhimin.
Development history and research progress of sentinel lymph node biopsy in breast cancer
[J]. China Oncology, 2023, 33(6): 551-559.
|
[7] |
BI Zhao, WANG Yongsheng.
New concept of de-escalation management strategy in breast cancer patients with 1-2 positive sentinel lymph nodes
[J]. China Oncology, 2023, 33(6): 560-565.
|
[8] |
ZHAO Qian, LING Yunxiao, LIU Guangyu.
Recent advances and perspectives in the application of repeat sentinel lymph node biopsy in breast cancer patients underwent breast-conserving surgery
[J]. China Oncology, 2023, 33(6): 566-573.
|
[9] |
CONG Binbin, CAO Xiaoshan, WANG Chuanjian, QIU Pengfei, SUN Xiao, CHEN Peng, LIU Yanbing, ZHAO Tong, ZHANG Zhaopeng, SHI Zhiqiang, BI Zhao, WANG Yongsheng.
Feasibility analysis of sentinel lymph node biopsy in breast cancer with axilla negative evaluation by physical examination but suspicious lymph nodes finding on preoperative imaging and metastasis confirmed with biopsy
[J]. China Oncology, 2023, 33(6): 574-580.
|
[10] |
DU Shuxiang, ZHAO Yingzhi, ZHANG Xuetao, WANG Tao, LUO Jingyu, ZHANG Wei, WU Gang.
Analysis of group 12a lymph node metastasis at different sites of gastric adenocarcinoma and its risk factors
[J]. China Oncology, 2023, 33(6): 597-604.
|
[11] |
HUANG He, JU Houyu, YANG Wenyi, YAN Ming, REN Guoxin, HU Jingzhou.
Clinical implication of PD-L2 in the prognosis assessment of HNSCC immunotherapy
[J]. China Oncology, 2023, 33(6): 613-618.
|
[12] |
YUAN Xinyue, YAO Yao, CHENG Shuai, ZHENG Xin, ZHANG Yuan.
Clinical study on high-risk factors for contralateral lymph node metastasis in unilateral papillary thyroid carcinoma
[J]. China Oncology, 2023, 33(6): 619-628.
|
[13] |
ZHANG Shaoqiu, YAN Li, LI Ruichen, ZHAO Yang, WANG Xiaoshen, YANG Xuguang, ZHU Yi.
Recent advances and prospect in immune microenvironment and its mechanisms of function in head and neck squamous cell carcinoma
[J]. China Oncology, 2023, 33(6): 629-636.
|
[14] |
BI Zhao, CHEN Peng, QIU Pengfei, CHEN Yuguang, WANG Yongsheng.
The analysis of axillary lymph nodes metastasis after neoadjuvant therapy in breast cancer
[J]. China Oncology, 2023, 33(4): 361-367.
|
[15] |
YANG Benlong, JIAO Dechuang, CHEN Jiajian, WANG Chunjian, JIN Lidan, ZHAO Wenhe, GAO Xueqiang, WANG Haibo, LI Jun, ZHAO Haidong, WU Di, FAN Zhimin, WANG Shujun, LIU Zhenzhen, WANG Yongsheng, WU Jiong.
Compared the efficacy of mitoxantrone hydrochloride injection for tracing with radionuclide in sentinel lymph node biopsy of breast cancer
[J]. China Oncology, 2023, 33(2): 126-133.
|